1. Home
  2. BIO vs CR Comparison

BIO vs CR Comparison

Compare BIO & CR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • CR
  • Stock Information
  • Founded
  • BIO 1952
  • CR 1855
  • Country
  • BIO United States
  • CR United States
  • Employees
  • BIO N/A
  • CR N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • CR Metal Fabrications
  • Sector
  • BIO Industrials
  • CR Industrials
  • Exchange
  • BIO Nasdaq
  • CR Nasdaq
  • Market Cap
  • BIO 9.2B
  • CR 9.4B
  • IPO Year
  • BIO N/A
  • CR N/A
  • Fundamental
  • Price
  • BIO $279.94
  • CR $165.10
  • Analyst Decision
  • BIO Strong Buy
  • CR Strong Buy
  • Analyst Count
  • BIO 4
  • CR 6
  • Target Price
  • BIO $414.00
  • CR $174.80
  • AVG Volume (30 Days)
  • BIO 273.5K
  • CR 302.1K
  • Earning Date
  • BIO 02-13-2025
  • CR 01-27-2025
  • Dividend Yield
  • BIO N/A
  • CR 0.56%
  • EPS Growth
  • BIO N/A
  • CR 13.69
  • EPS
  • BIO N/A
  • CR 5.05
  • Revenue
  • BIO $2,566,500,000.00
  • CR $2,131,199,999.00
  • Revenue This Year
  • BIO $4.19
  • CR $9.28
  • Revenue Next Year
  • BIO $4.75
  • CR $6.57
  • P/E Ratio
  • BIO N/A
  • CR $35.88
  • Revenue Growth
  • BIO N/A
  • CR 2.15
  • 52 Week Low
  • BIO $262.12
  • CR $121.07
  • 52 Week High
  • BIO $387.99
  • CR $188.52
  • Technical
  • Relative Strength Index (RSI)
  • BIO 26.04
  • CR 45.76
  • Support Level
  • BIO $273.67
  • CR $167.88
  • Resistance Level
  • BIO $289.96
  • CR $173.67
  • Average True Range (ATR)
  • BIO 11.05
  • CR 3.76
  • MACD
  • BIO -6.71
  • CR -0.65
  • Stochastic Oscillator
  • BIO 7.40
  • CR 5.33

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About CR Crane Company

Crane is a diversified industrial firm that manufactures a broad range of products, including valves, pumps, aerospace components, and fiberglass-reinforced plastic panels. Its business is organized into three segments: aerospace and electronics, process flow technologies, and engineered materials. Crane generated approximately $2.1 billion in revenue in 2023.

Share on Social Networks: